Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors

Evidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains suboptimal. This review seeks to map social factors mediating HCV treatment access.

Combination intervention approaches need to encompass social interventions in relation to housing, stigma reduction and systemic changes in policy and health care delivery. Future research needs to better delineate social factors affecting treatment access.

Click here to read the full publication (restricted access)

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.